Blood Pressure Control at the Diabetes Planned Visit
Diabetes planned visits address several health topics of
concern to the diabetic patient, including high blood pressure. This document
offers a guideline for developing a blood pressure goal.
Blood Pressure Control
BP control (<130/70) reduces MI, stroke and death more
than blood sugar control.
- BP of 132/79 reduces all cause
mortality 49% (ABCD study).
- Hypertension
contributes to up 75% of diabetes related complications.
- 80% of people
with diabetes die of heart attacks and strokes.
- Risk of
cardiovascular disease doubles for every increase of 20 mm Hg in systolic blood
pressure and every 10 mm Hg diastolic blood pressure starting at 115/75.
BP goal is <125/70 if proteinuria is present or GFR <60.
Each 10 mmHg reduction of systolic blood pressure reduces:
- Diabetic
complications 12% , myocardial infarction 11%, microvascular complications 13%.
Stepwise approach to reaching blood pressure goal in
DMa
Step 1: Lifestyle modification:b
- Low-sodium, high
potassium, low calorie, high-fiber foods.
- Increased
physical activity (Walking to 35 to 45 minutes 3 to 5 days/week).
Step 2: Thiazide diuretic (HCTZ , chlorthalidone).
Step 3: Add ACE inhibitor.
Step 4: If diabetic
nephropathy (microalbuminuria ≥30) present or GFR <60:a,c
Add ARB to ACE
- ACE and ARB titrated to target
dose even if at goal BP.
Step 5: Add beta blocker (BB) or calcium channel blocker (CCB):
- BB first if S/P MI,
CABG or angioplasty.
- Use long acting non dihydropyridine channel blocker (CCB).
e.g., verapamil, diltiazem.
Step 6a: If pulse greater than or equal to 84:
- Add low-dose
beta blockerd or alpha blocker.
- If still not at
target add at long acting alpha blockere or low dose beta blocker nightly.
Step 6b: If baseline pulse is <84:
- Add other
subgroup of calcium channel blocker.
(e.g., amlodipine if
verapamil or diltiazem has been used)
Step 7: Consider referral to nephrologist or cardiologist if not
at target BP.
a. Always include lifestyle modification.
b. Move through successive steps until goal BP is reached.
c. Use steps 1-4 if microalbuminuria / proteinura or GFR
< 60 cc/min, regardless of BP.
d. Special note: Use of beta blocker with a
nondihydropyridine CCB (verapamil, diltiazem) should be avoided in the elderly
and those with conduction abnormalities, instead choose hydralazine, clonidine,
minoxidil or methyldopa.
e. Special note: Clonidine should not be used with beta
blockers because of the risk of severe bradycardia.
Causes of inadequate response to
antihypertensive therapy
- Excess salt intake.
- Progressive renal damage.
- EtOH >2 oz. per day.
- Fluid retention.
- Inadequate diuretic therapy.
- Obesity.
- Smoking.
- NSAIDs.
- Sleep apnea.
- Antidepressants.
- Oral contraceptives.
- Caffeine.
- Appetite suppressants.
Diuretics
Hydrochlorothiazide (HCTZ)
- Typical hydrochlorothiazide dose
12.5 mg-25 mg daily.
- Ineffective if creatinine clearance
<30 cc/min, creatinine >2.5.
Loop diuretics (furosemide, Lasix)
- Most effective if creatinine
clearance <30 to 40 cc/min.
- High doses given twice daily may be
needed.
Beta blockers (BB)
- ß-1
selective BB do NOT increase the risk of masking hypoglycemia.
- Propranolol may
reduce tremulousness/hunger, not diaphoresis/impaired cognition.
- Consider
cardioselective BB agent (carvedilol [Coreg]); Improves insulin sensitivity.
- Monitor for; bradycardia,
CHF, wheezing fatigue, insomnia, cold extremities.
Calcium channel blockers (CCBs)
- Use only long
acting formulations.
- Only amlodipine
should be used in CHF.
- Monitor for
ankle edema, dizziness, flushing and headache.
Non-dihydropyridines
Dihydropridines
- Amlodipine, nisoldipine, felodipine,
isradipine, nicardipine.
- Nifedipine (do not use to treat
hypertension).
Verapamil (Effective Max 240mg/day)
- Preferred calcium channel blocker.
- Contraindications: AV node dysfunction with 2nd or
3rd degree AV block, systolic heart failure, decreased LV function.
- Monitor for bradycardia and heart block.
Diltiazem (Max 480 mg)
- May use in atrial fibrillation, angina, ischemia.
ACE/ARB
- Consider holding diuretic for 24-48 hours prior to beginning
ACE to avoid hypotension.
- Obtain baseline serum potassium, creatinine and BUN, repeat BMP
within 2 weeks.
Rising creatinine > 30% above baseline
- Usually due to volume depletion, thus not a reason to avoid
ACE indefinitely.
- If creatinine rises > 30, but
< 50%, hold ACE and diuretic, normalize volume status, and repeat BMP in 4-7
days.
- Resume ACE when creatinine at
baseline.
- Renal artery stenosis is a contraindication to ACE ARB.
- Suspect if, in the absence of heart
failure and volume depletion, creatinine rises >30%.
- Suspect if creatinine continue to
rise over 1st 2 months of therapy.
- Suspect if creatinine rises > 50%
from baseline.
Lisinopril (Start 5-10 mg QD, double Q 2weeks, Max 80mg QD)
Losartan (Cozaar) Start 25mg QD, double Q 2 weeks, Max 100mg QD)
Valsartan (Diovan) Start 40mg QD, double Q 2 weeks Max 320mg QD)
Return to Diabetes Planned Visit Notebook Contents
Proceed to Next Section